113 related articles for article (PubMed ID: 21237393)
1. Rituximab-containing therapy for chronic lymphocytic leukaemia.
Haines I; Elliott P; Stanley R
Lancet; 2011 Jan; 377(9761):205; author reply 206. PubMed ID: 21237393
[No Abstract] [Full Text] [Related]
2. Rituximab-containing therapy for chronic lymphocytic leukaemia.
Tanimoto T; Sakiyama M; Hori A; Yagasaki F; Kami M
Lancet; 2011 Jan; 377(9761):205; author reply 206. PubMed ID: 21237394
[No Abstract] [Full Text] [Related]
3. [Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab].
Tsukasaki K
Nihon Rinsho; 2015 Feb; 73 Suppl 2():632-5. PubMed ID: 25831837
[No Abstract] [Full Text] [Related]
4. Making advances in first-line chronic lymphocytic leukemia treatment.
Wierda WG
J Clin Oncol; 2012 Sep; 30(26):3162-4. PubMed ID: 22869876
[No Abstract] [Full Text] [Related]
5. Chemoimmunotherapy in chronic lymphocytic leukemia.
Stilgenbauer S
Clin Adv Hematol Oncol; 2010 Dec; 8(12):867-8. PubMed ID: 21326163
[No Abstract] [Full Text] [Related]
6. Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study.
Goede V; Fischer K; Engelke A; Schlag R; Lepretre S; Montero LF; Montillo M; Fegan C; Asikanius E; Humphrey K; Fingerle-Rowson G; Hallek M
Leukemia; 2015 Jul; 29(7):1602-4. PubMed ID: 25634683
[No Abstract] [Full Text] [Related]
7. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
8. Twice-daily pill could treat leukemia.
Printz C
Cancer; 2014 Aug; 120(15):2225. PubMed ID: 25047250
[No Abstract] [Full Text] [Related]
9. Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
Chow KU; Kim SZ; von Neuhoff N; Schlegelberger B; Stilgenbauer S; Wunderle L; Cordes HJ; Bergmann L
Eur J Haematol; 2011 Nov; 87(5):426-33. PubMed ID: 21749447
[TBL] [Abstract][Full Text] [Related]
10. Agranulocytosis occurring in a patient with chronic lymphocytic leukemia in complete remission; treatment by rituximab and cyclosporin.
Costello RT; Sébahoun G
Leuk Res; 2010 Dec; 34(12):e329-30. PubMed ID: 20723978
[No Abstract] [Full Text] [Related]
11. Bendamustine in chronic lymphocytic leukemia: the future is combination therapy.
Friedberg JW
Leuk Lymphoma; 2009 Sep; 50(9):1399-400. PubMed ID: 19811324
[No Abstract] [Full Text] [Related]
12. Combination therapy with ofatumumab and bendamustine in xenograft model of chronic lymphocytic leukaemia.
Haskova Z; Whitacre MN; Dede KA; Lee JM; Trulli SH; Ciucci M; Toso JF; White JR; Jonak ZL
Br J Haematol; 2012 Feb; 156(3):402-4. PubMed ID: 21848524
[No Abstract] [Full Text] [Related]
13. [Practical considerations and questions in the treatment of chronic lymphocytic leukemia].
Telek B; Rejto L; Batár P; Reményi G; Szász R; Kiss A; Udvardy M
Orv Hetil; 2011 Jun; 152(24):958-63. PubMed ID: 21609922
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment of leukemia cutis with combination of rituximab, cladribine, and cyclophosphamide in patient with B-cell chronic lymphocytic leukemia.
Batycka-Baran A; Baran W; Dzietczenia J; Mazur G
Ann Hematol; 2011 Aug; 90(8):979-80. PubMed ID: 20978760
[No Abstract] [Full Text] [Related]
15. Chronic lymphocytic leukemia with nuclear budding.
Huang JZ; Folbe MH; Richards SK; Kolins MD
Eur J Haematol; 2012 Jan; 88(1):92. PubMed ID: 21801234
[No Abstract] [Full Text] [Related]
16. A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.
Hillmen P; Cohen DR; Cocks K; Pettitt A; Sayala HA; Rawstron AC; Kennedy DB; Fegan C; Milligan DW; Radford J; Mercieca J; Dearden C; Ezekwisili R; Smith AF; Brown J; Booth GA; Varghese AM; Pocock C;
Br J Haematol; 2011 Mar; 152(5):570-8. PubMed ID: 21231927
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of lymphomatoid papulosis during rituximab therapy.
McCurdy O; McCormack C; Ritchie D; Prince HM
Australas J Dermatol; 2014 Feb; 55(1):e1-3. PubMed ID: 23190403
[TBL] [Abstract][Full Text] [Related]
18. Severe infusion-related reactions are uncommon in rituximab-treated CLL patients in clinical practice: results from a Swedish national observational study.
Norin S; Björkstrand B; Rommel F; Timberg L; Andersson PO; Häggström J; Aldrin A; Hansson L
Leuk Res; 2015 Jan; 39(1):33-7. PubMed ID: 25499233
[TBL] [Abstract][Full Text] [Related]
19. Bendamustine and rituximab for indolent B-cell non-hodgkin lymphoma in patients with compensated hepatitis C cirrhosis: a case series.
Parker SM; Hyder MA; Fesler MJ
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):e15-7. PubMed ID: 24060287
[No Abstract] [Full Text] [Related]
20. Cocirculating precursor B acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Huang Q
Blood; 2013 Sep; 122(13):2148. PubMed ID: 24195124
[No Abstract] [Full Text] [Related]
[Next] [New Search]
